Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Roland

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Focus (San Francisco, Calif.)|May 22, 2001
Antiviral adherence dilemmasM E Roland
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2006
Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipientsJ T Carter, M L Melcher, L L Carlson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2007
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipientsL A Frassetto, M Browne, A Cheng, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 5, 2014
Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsP G Stock, B Barin, H Hatano, et al.
The Journal of Infectious Diseases|February 22, 2001
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP StudyJ O Kahn, J N Martin, M E Roland, et al.
The Journal of Infectious Diseases|December 12, 2001
Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposureM E Roland, J N Martin, R M Grant, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 6, 2012
Liver transplant outcomes in HIV+ haemophilic menM V Ragni, M E Devera, M E Roland, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2010
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipientsC S Coffin, P G Stock, L M Dove, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 21, 2007
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomesM E Roland, B Barin, L Carlson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Focus (San Francisco, Calif.)|May 22, 2001
Antiviral adherence dilemmasM E Roland
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2006
Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipientsJ T Carter, M L Melcher, L L Carlson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2007
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipientsL A Frassetto, M Browne, A Cheng, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 5, 2014
Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsP G Stock, B Barin, H Hatano, et al.
The Journal of Infectious Diseases|February 22, 2001
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP StudyJ O Kahn, J N Martin, M E Roland, et al.
The Journal of Infectious Diseases|December 12, 2001
Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposureM E Roland, J N Martin, R M Grant, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 6, 2012
Liver transplant outcomes in HIV+ haemophilic menM V Ragni, M E Devera, M E Roland, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2010
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipientsC S Coffin, P G Stock, L M Dove, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 21, 2007
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomesM E Roland, B Barin, L Carlson, et al.
Pageof 1